Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 15, 2019 - Issue 10
Submit an article Journal homepage
604
Views
18
CrossRef citations to date
0
Altmetric
Review

Pharmacokinetics and pharmacodynamics of pegylated interferon for the treatment of hepatitis B

Ming-Lun YehHepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;School of Medicine and Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanView further author information
,
Jee-Fu HuangHepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;School of Medicine and Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;Center for Cancer Research and Center for Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, TaiwanView further author information
,
Chia-Yen DaiHepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;School of Medicine and Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;Center for Cancer Research and Center for Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, TaiwanView further author information
,
Ming-Lung YuHepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;School of Medicine and Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;Center for Cancer Research and Center for Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, Taiwan;Center for Intelligent Drug Systems and Smart Bio-devices (IDSB) and Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsin-Chu, Taiwan;Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, TaiwanView further author information
&
Wan-Long ChuangHepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;School of Medicine and Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;Center for Cancer Research and Center for Liquid Biopsy, Kaohsiung Medical University, Kaohsiung, TaiwanCorrespondence[email protected]
View further author information
Pages 779-785 | Received 27 Jun 2019, Accepted 07 Oct 2019, Published online: 12 Oct 2019

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ming-Lun Yeh, Jee-Fu Huang, Ming-Lung Yu & Wan-Long Chuang. (2021) Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa. Expert Review of Gastroenterology & Hepatology 15:4, pages 427-435.
Read now

Articles from other publishers (17)

Harry L. Janssen, Young-Suk Lim, Hyung Joon Kim, Leonard Sowah, Cheng-Hao Tseng, Carla S. Coffin, Magdy Elkhashab, Sang Hoon Ahn, Anh-Hoa Nguyen, Diana Chen, Jeffrey J. Wallin, Simon P. Fletcher, Circe McDonald, Jenny C. Yang, Anuj Gaggar, Diana M. Brainard, Scott Fung, Yoon Jun Kim, Jia-Horng Kao, Wan-Long Chuang, Anna E. Brooks & P. Rod Dunbar. (2023) Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection. JHEP Reports, pages 100975.
Crossref
Boris Nikolaev, Ludmila Yakovleva, Viacheslav Fedorov, Natalia Yudintceva, Vyacheslav Ryzhov, Yaroslav Marchenko, Alexander Ischenko, Alexander Zhakhov, Anatoliy Dobrodumov, Stephanie E. Combs, Huile Gao & Maxim Shevtsov. (2023) Magnetic Relaxation Switching Assay Using IFNα-2b-Conjugated Superparamagnetic Nanoparticles for Anti-Interferon Antibody Detection. Biosensors 13:6, pages 624.
Crossref
Takuo Ogihara, Kenta Mizoi & Akiko Ishii-Watabe. (2023) Pharmacokinetics of Biopharmaceuticals: Their Critical Role in Molecular Design. Biomedicines 11:5, pages 1456.
Crossref
Haiying Luo, Xiaoxia Hu, Yadi Li, Dingjia Lei, Guili Tan, Yueying Zeng & Bo Qin. (2023) The antiviral activity of tripartite motif protein 38 in hepatitis B virus replication and gene expression and its association with treatment responses during PEG-IFN-α antiviral therapy. Virology 579, pages 84-93.
Crossref
绾 厉. (2023) Clinical Survey of Different Treatment Methods for Chronic Viral Hepatitis B. Advances in Clinical Medicine 13:07, pages 11108-11112.
Crossref
Wen-Xin Wang, Rui Jia, Jin-Wen Song, Xiaoning Zhang, Shuang-Nan Zhou, Fu-Sheng Wang & Junliang Fu. (2022) Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy. Frontiers in Microbiology 13.
Crossref
Jiao Yu & Dong Xu. (2022) Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C. Contrast Media & Molecular Imaging 2022, pages 1-8.
Crossref
Elisabetta Loggi, Stefano Gitto, Filippo Gabrielli, Elena Franchi, Hajrie Seferi, Carmela Cursaro & Pietro Andreone. (2022) Virological Treatment Monitoring for Chronic Hepatitis B. Viruses 14:7, pages 1376.
Crossref
Linggai Cao, Lili ZhangXiaolian ZhangJia LiuMeng-Ao JiaJishun ZhangJiemin LiuFeng Wang. (2022) Types of Interferons and Their Expression in Plant Systems. Journal of Interferon & Cytokine Research 42:2, pages 62-71.
Crossref
Jiayi Wang, Lingyao Du & Hong Tang. (2021) Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection. Frontiers in Medicine 8.
Crossref
Derry K Mercer, Marie-Louise FrancisDouglas Fraser-Pitt. (2021) Antimicrobial immunotherapeutics: past, present and future. Emerging Topics in Life Sciences 5:5, pages 609-628.
Crossref
Ming‐Lun Yeh, Po‐Cheng Liang, Ching‐I Huang, Meng‐Hsuan Hsieh, Yi‐Hung Lin, Tyng‐Yuan Jang, Yu‐Ju Wei, Po‐Yao Hsu, Cheng‐Ting Hsu, Chih‐Wen Wang, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang & Ming‐Lung Yu. (2021) Seroreversion of hepatitis B surface antigen among subjects with resolved hepatitis B virus infection: A community‐based cohort study. Journal of Gastroenterology and Hepatology 36:11, pages 3239-3246.
Crossref
Ming-Lun Yeh, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Chi-Yi Chen, Hsing-Tao Kuo, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Chi‐Ming Tai, Chih-Wen Lin, Jia-Horng Kao, Chen-Hua Liu, Sheng-Lei Yan, Ming-Jong Bair, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Pei-Chien Tsai, Cheng-Yuan Peng, Chun-Jen Liu & Ming-Lung Yu. (2021) Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH). Hepatology International 15:5, pages 1109-1121.
Crossref
Mariangela Stinco, Chiara Rubino, Sandra Trapani & Giuseppe Indolfi. (2021) Treatment of hepatitis B virus infection in children and adolescents. World Journal of Gastroenterology 27:36, pages 6053-6063.
Crossref
Patricia Holanda Almeida, Celso E L Matielo, Lilian A Curvelo, Rodrigo A Rocco, Guilherme Felga, Bianca Della Guardia & Yuri L Boteon. (2021) Update on the management and treatment of viral hepatitis. World Journal of Gastroenterology 27:23, pages 3249-3261.
Crossref
Tyng-Yuan Jang, Yu-Ju Wei, Ta-Wei Liu, Ming-Lun Yeh, Shu-Fen Liu, Cheng-Ting Hsu, Po-Yao Hsu, Yi-Hung Lin, Po-Cheng Liang, Meng-Hsuan Hsieh, Yu-Min Ko, Yi-Shan Tsai, Kuan-Yu Chen, Ching-Chih Lin, Pei-Chien Tsai, Shu-Chi Wang, Ching-I. Huang, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang, Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang & Ming-Lung Yu. (2021) Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues. Scientific Reports 11:1.
Crossref
Margarita Papatheodoridi & George Papatheodoridis. 2021. Hepatitis B Virus and Liver Disease. Hepatitis B Virus and Liver Disease 267 285 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.